Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due to personal reasons, it has emerged. Furthermore, it has been announced that current Global Head of the Oncology Discovery and Translational Area for pRED, Dr William Pao, will succeed him in the role, effective 2 April.
Ook interessant voor je
Reageer